Autosomal dominant aplasia and myelodysplasia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Dec 2023Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING
Feb 2017French National Registry of Bone Marrow Failures

Assistance Publique - Hôpitaux de Paris — NA

TrialRECRUITING
Jan 2017Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Mayo Clinic — NA

TrialRECRUITING
Aug 2013Natural History Study of GATA2 Deficiency and Related Disorders

National Institute of Allergy and Infectious Diseases (NIAID)

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Autosomal dominant aplasia and myelodysplasia.
Check the disease page for updates →

Clinical Trial Landscape

4 active trials
1Phase 1
2N/A
1Unknown
4Total recruiting
Search clinical trials for Autosomal dominant aplasia and myelodysplasia

Recent News & Research

No recent news articles indexed yet for Autosomal dominant aplasia and myelodysplasia.
Search PubMed for Autosomal dominant aplasia and myelodysplasia

Browse all Autosomal dominant aplasia and myelodysplasia news →

Specialist Network

No specialists currently listed for Autosomal dominant aplasia and myelodysplasia.

View all Autosomal dominant aplasia and myelodysplasia specialists →

Quick Actions